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ABSTRACT 
We report here our experimental findings of new nonlocal biological effect measured objectively 
and quantitatively under blind conditions. The method used includes the steps of providing two 
parts of quantum-entangled medium, applying one part to a biological system such as a human, 
contacting the other part with a desired substance such as a medication, and detecting change of 
a biological parameter with a detecting device. Using this method, we have found that after 
consumption by a test subject of one part of the quantum entangled water, the subject’s heart rate 
was non-locally increased under blind conditions by adding to the second part of the 
quantum-entangled water an over-the-counter medication Primatene which contains the heart 
stimulant ephedrine. The said increase of heart rate is measurable with a heart rate monitor, 
statistically significant and consistently reproducible. 
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1. Introduction 
We previously found nonlocal biological effects of various substances measured by first-person 
experiences of the voluntary test subjects [1, 2]. We then found nonlocal thermal, chemical and 
gravitational effects in simple physical systems measured by high-precision instruments [3, 4].  
We report here our findings of new nonlocal biological effect measured objectively and 
quantitatively under blind conditions. The method we used includes the steps of providing two 
parts of a quantum-entangled medium, applying one part to a biological system such as a human, 
contacting the other part with a desired substance such as a medication, and detecting change of 
a biological parameter with a detecting device. 
Between the time of our previous findings and the present, there have been reports of 
macroscopic quantum entanglements by other groups. For example, entanglement of 
macroscopic diamonds at room temperature has been reported [5]; entanglement in 
photosynthetic light harvesting complexes has been calculated to exist [6]; and evidence of 
potential macroscopic entanglement between brain activities has also been reported [7].  
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2. Methods, Materials and Test Subjects 
As shown on the left side of Figure 1, the essential steps of producing a nonlocal biological 
effect in one of our methods include preparing two equal parts qe1 and qe2 of a 
quantum-entangled medium qe, applying one part qe1 to a voluntary test subject h, and 
contacting the other part qe2 with a desired substance s such as a particular medication or 
substance encoded with a message whereby non-local effect of the substance on the said test 
subject is produced. 
As shown on the right side of Figure 1, the essential steps of objectively and quantitatively 
detecting and measuring said non-local effect in said test subject includes providing a detecting 
device such as a heart rate monitor comprising a heart rate probe p attached to the chest area of 
the test subject and a display mechanism d connected to said probe p, or a wireless probe plus 
transmitter p attached to said the chest area of said test subject and a wireless receiver plus 
display mechanism d, and detecting a change of a physical, chemical or biological parameter 
such as heart rate of the human produced nonlocally by said substance. 
 
Figure 1. Key Experimental Setup 
In particulars, the experiments were conducted under blind conditions in that the voluntary test 
subject did not know any detail of the experiment and the detecting and measuring person did not 
know the exact time when a substance was added. The quantum entangled medium used was 
microwaved water prepared as follows: 400ml Poland Spring water in a plastic ware with a shelf 
time of at least three months was exposed to the radiation of microwave oven with a 1500 Watt 
output for 1min as illustrated in Figure 1. The medication used was Primatene prepared as 
follows: Five (5) tablets of Primatene (containing a total of 60mg ephedrine, a heart stimulant) 
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were crushed into powder and dissolved into 10ml water. Primatene is an over-the-counter 
medication for asthma.  
The test subject then immediately consumed one-half of the water so exposed as described 
above. After 30min from the time of consumption, the 10ml solution of Primatene was added 
into the other half of the microwaved water by a person in a different room about 50 feet away 
from the test subject and at a time not known by the test subject or the person measuring and 
recording the heart rate. The time series of heart rate were measured as shown in Figure 1 with a 
Polar FT4 wireless heart rate monitor and recorded by hand at the interval of every 0.1min (6sec) 
before, during and after Primatene was added into the other half of the microwaved water.  
With respect to the test subjects, Subject A and C are respectively the first author and co-author 
of this paper and Subject B is the father of the first author. All three test subjects voluntarily 
consented to the proposed experiments. To ensure safety, all initial experiments were conducted 
on Subject A by himself. Further, over-the-counter medication Primatene used in the study was 
properly obtained for research purpose.  
 
3. Results 
Figure 2 shows 3D Charts of five (5) data sets from experiments conducted on Subject B as 
described previously with each set comprising a test and baseline (control) time series of heart 
rate.  
 
Preprint (Released on 06/20/2012) 
Hu, H. & Wu, M., New Nonlocal Biological Effect  
4 
 
Figure 2. 3D Charts of five (5) data sets from experiments conducted on Subject B 
The upper 3D chart displays the time series of heart rate with 10ml solution of five (5) tablets of 
Primatene (containing 60mg ephedrine) being added at the marked time of four (4) minute. The 
lower 3D chart displays the control data (baseline) obtained before any Primatene was added to 
the second half of the microwaved water (starting at 15 minute after Subject B consumed the first 
half of the microwaved water). 
Figure 3 shows the charts of test and control averages on data obtained on Subject B and 
displayed in Figure 1.  
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Figure 3. Charts of test and control averages of five data sets obtained on Subject B 
 
For further illustration, Figure 4 shows the time series charts of Test1 and Control1 obtained on 
Subject B.  
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Figure 4. Charts of Test1 and Control1 data set obtained on Subject B 
As another example, Figure 5 shows the charts of time series of Test2 and Control2 obtained on 
Subject B.  
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Figure 5. Charts of Test2 and Control2 data set obtained on Subject B 
It is clear from the above data shown in Figures 2-5 that while the baselines (controls) of the 
heart rate of Subject B are stable, and fluctuate and drift within the ranges of five (5) points 
(beats), Primatene solution containing 60mg ephedrine produced detectable non-local effect in 
Subject B in the form of rapidly increased heart rate for at least four (4) minutes in the range of 
1-6 points (beats) or 1.5%-10% above the fluctuating ranges of the baselines. 
The increase of heart rate in Subject B non-locally induced by Primatene is statistically 
significant because: (1) The timing of the increase in heart rate coincide with the time of adding 
Primatene; (2) Averaging of the time series does not cancel the signal as random noises would as 
shown in Figure 3; and (3) Assuming normal (Gaussian) distribution, we did student’s t-tests 
comparing data points within 4 minutes (forty data points) immediately after adding Primatene 
(Sample1)and the data points within 4 minutes (forty data points) immediately before adding 
Primatene (Sample2) which all show statistically significant differences as listed in Table 1 
below: 
                   Table 1                  
------------------------------------------------------------------------------------------------------  
Test1   Size  Mean  Std. Dev.  SE Mean 
Sample1  40  71.65  2.6559  0.42 
Sample2  40  66   1.1323  0.179 
Observed difference (Sample 1 - Sample 2):     5.65 
Standard Deviation of Difference:      0.4565 
Degree of Freedom:        52 
95% Confidence Interval for the Difference:    (4.734, 6.566) 
T-Value:           12.3768  
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Population 1 ≠ Population 2:       P-Value = < .00001  
Population 1 > Population 2:       P-Value = >.99999  
Population 1 < Population 2:       P-Value = < .00001  
-------------------------------------------------------------------------------------------- ---------- 
Test2    Size  Mean  Std. Dev.  SE Mean 
Sample 1  40  62.575  1.3376  0.211 
Sample 2  40  61.35  0.7355  0.116 
Observed difference (Sample 1 - Sample 2):     1.225 
Standard Deviation of Difference:      0.2414 
Degree of Freedom:        60 
95% Confidence Interval for the Difference:    (0.7421, 1.7079) 
T-Value:           5.0746  
Population 1 ≠ Population 2:       P-Value = < .00001  
Population 1 > Population 2:       P-Value = >.99999  
Population 1 < Population 2:       P-Value = < .00001  
 
---------------------------------------------------------------------------------------- -------------- 
Test3   Size  Mean  Std. Dev.  SE Mean 
Sample 1  40  65.15  2.0946  0.331 
Sample 2  40  61.175  2.0492  0.324 
Observed difference (Sample 1 - Sample 2):     3.975 
Standard Deviation of Difference:      0.4633 
Degree of Freedom:         77 
95% Confidence Interval for the Difference     (3.0524, 4.8976) 
T-Value:           8.5798  
Population 1 ≠ Population 2:       P-Value = < .00001  
Population 1 > Population 2:       P-Value = >.99999  
Population 1 < Population 2:       P-Value = < .00001  
 
---------------------------------------------------------------------------------------- -------------- 
Test4   Size  Mean  Std. Dev.  SE Mean 
Sample 1  40  64   0.9608  0.152 
Sample 2  40  62.75  0.9541  0.151 
Observed difference (Sample 1 - Sample 2):     1.25 
Standard Deviation of Difference:      0.2141 
Degree of Freedom:        77 
95% Confidence Interval for the Difference:    (0.8237, 1.6763) 
T-Value:           5.8384  
Population 1 ≠ Population 2:       P-Value = < .00001  
Population 1 > Population 2:       P-Value = >.99999  
Population 1 < Population 2:       P-Value = < .00001  
 
---------------------------------------------------------------------------------------- -------------- 
Test5   Size  Mean  Std. Dev.  SE Mean 
Sample 1  40  61.525  1.3006  0.206 
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Sample 2  40  59.775  1.2297  0.194 
Observed difference (Sample 1 - Sample 2):     1.75 
Standard Deviation of Difference:      0.283 
Degree of Freedom:        77 
95% Confidence Interval for the Difference:    (1.1865, 2.3135) 
T-Value:           6.1837  
Population 1 ≠ Population 2:       P-Value = < .00001  
Population 1 > Population 2:       P-Value = >.99999  
Population 1 < Population 2:       P-Value = < .00001  
------------------------------------------------------------------------------------------------------  
Figures 6 and 7 shows two (2) sets of experimental data obtained on Subject C with the same 
procedure as that used on Subject B, each set comprising a test and a control (baseline), 10ml 
solution of five (5) tablets of Primatene (containing 60mg ephedrine) being added at the marked 
time of four (4) minute: 
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Figure 6. Charts of Test1 and Control1 data set obtained on Subject C 
 
Figure 7. Charts of Test2 and Control2 data set obtained on Subject C 
It can be seen from the data shown in Figures 6 and 7, while the baselines (controls) of the heart 
rate of Subject C are stable and fluctuate within the ranges of five (6) points (beats), Primatene 
solution containing 60mg ephedrine produced detectable non-local effect in Subject C in the 
form of rapidly increased heart rate for at least two (2) minutes in the range of 1-4 points (beats) 
or 1.5%-6% above the fluctuating ranges of the baselines. 
Assuming normal (Gaussian) distribution, we again did student’s t-test on data sets collected on 
Subject C comparing data points within 4 minutes (forty data points) immediately after adding 
Primatene (Sample1) and the data points within 4 minutes (forty data points) immediately before 
adding Primatene (Smaple2) which show statistically significant differences as shown in Table 2 
below: 
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                               Table 2         
-------------------------------------------------------------------------------------------------- ---- 
Test1   Size  Mean  Std. Dev.  SE Mean 
Sample 1  40  74.45  2.4698  0.391 
Sample 2  40  72.725  1.198  0.189 
Observed difference (Sample 1 - Sample 2):     1.725 
Standard Deviation of Difference:      0.434 
Degree of Freedom:        56 
95% Confidence Interval for the Difference:     (0.8556, 2.5944) 
T-Value:          3.9747  
Population 1 ≠ Population 2:       P-Value = 0.0002  
Population 1 > Population 2:       P-Value = 0.9999  
Population 1 < Population 2:       P-Value = 0.0001  
 
------------------------------------------------------------------------------------------------------  
Test2   Size  Mean  Std. Dev.  SE Mean 
Sample 1  40  63.625  1.3902  0.22 
Sample 2  40  62.725  0.9055  0.143 
Observed difference (Sample 1 - Sample 2):     0.9 
Standard Deviation of Difference:      0.2623 
Degree of Freedom:         67 
95% Confidence Interval for the Difference:    (0.3764, 1.4236) 
T-Value:           3.4312  
Population 1 ≠ Population 2:       P-Value = 0.001  
Population 1 > Population 2:       P-Value = 0.9995  
Population 1 < Population 2:       P-Value = 0.0005 
------------------------------------------------------------------------------------------------ ------  
Finally, experiments conducted on Subject A with Primatene while exploring the parameters of 
experimental setup also showed increased heart rate in Subject A.   
 
4. Conclusions & Discussions 
In this new study, we have found that after consumption by a test subject of one part of the 
quantum entangled water, the subject’s heart rate was non-locally increased under blind 
conditions by adding to the second part of the quantum-entangled water an over-the-counter 
medication Primatene which contains the heart stimulant ephedrine. The said increase of heart 
rate is measurable with a heart rate monitor, statistically significant and consistently 
reproducible. 
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The results obtained herein extend our results obtained in [1-4] and can be easily verified by any 
competent researcher in a proper/professional setting. However, please use caution as improper 
dosage may cause fast heart beat above normal range, panic attack or maybe worse. Anyone who 
is allergic or otherwise sensitive to Primatene (ephedrine), or has a heart problem and/or high 
blood pressure should refrain from participating in any testing even in a proper/professional 
setting. For safety reason, amateurs should not attempt any testing on their own. 
This new study reaffirms our earlier conclusions [1-4]. First, biologically/chemically meaningful 
information can be transmitted through quantum entanglement mediated processes from one 
place to another. Second, both classical and quantum information can be transmitted between 
different locations through quantum entanglement alone. Third, instantaneous signaling is 
physically real which implies that Einstein's theory of relativity needs new interpretation as we 
have done in [8-9]. Further, our new findings provide important insights into the essence and 
implications of the quantum entanglement. Very importantly, our findings also assist the 
establishment of a unified scientific framework for explaining many paranormal and/or 
anomalous effects such as telepathy, telekinesis and homeopathy, if they do indeed exist, thus 
transforming these paranormal and/or anomalous effects into the domains of conventional 
sciences. 
With respect applications, our findings enable various quantum entanglement technologies be 
developed. Some of these technologies can be used to deliver the therapeutic effects of many 
drugs to various biological systems such as human bodies without physically administrating the 
same to the said systems. Further, many substances of nutritional and recreational values can be 
repeatedly administrated to desired biological systems such as human bodies through the said 
technologies either on site or from remote locations. Other such technologies can be used for 
instantaneous communications between remote locations of arbitrary distances in various ways. 
Potentially, these technologies can also be used to entangle two or more human minds for 
legitimate and beneficial purposes. 
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